Racial differences in the impact of comorbidities on survival among elderly men with prostate cancer

Medical Care Research and Review

Volumn 66, Issue 4, 2009, Pages 409-435

  Putt, Mary ^a   Long, Judith A ^a,b   Montagnet, Chantal ^a   Silber, Jeffrey H ^a,c,d   Chang, Virginia W ^a,b   Liao, Kaijun ^a   Schwartz, J Sanford ^a   Pollack, Craig Evan ^a,b   Wong, Yu Ning ^a   Armstrong, Katrina ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Administrative data; Comorbidity; Disparities; Medicare; Prostate cancer; Social epidemiology; Survival analysis

Indexed keywords

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MEDICARE; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 68149164598     PISSN: 10775587     EISSN: 15526801     Source Type: Journal    
DOI: 10.1177/1077558709333996     Document Type: Article

References (43)

1. Alibhai, S.M., Leach, M., Tomlinson, G., Krahn, M.D., Fleshner, N., Holowaty, E., et al. (2005). 30-Day mortality and major complications after radical prostatectomy: Influence of age and comorbidity. Journal of the National Cancer Institute, 97, 1525-1532.
2. Armstrong, K., Ravenell, K.L., McMurphy, S., & Putt, M. (2007). Racial/ethnic differences in physician distrust in the United States. American Journal of Public Health, 97, 1283-1289.
3. Asch, D.A., & Armstrong, K. (2007). Aggregating and partitioning populations in health care disparities research: Differences in perspective. Journal of Clinical Oncology, 25, 2117-2121.
4. Begg, C.B., Riedel, E.R., Bach, P.B., Kattan, M.W., Schrag, D., Warren, J.L., et al. (2002). Variations in morbidity after radical prostatectomy. New England Journal of Medicine, 346, 1138-1144.
5. Chirinos, J.A., Veerani, A., Zambrano, J.P., Schob, A., Perez, G., Mendez, A.J., et al. (2007). Evaluation of comorbidity scores to predict all-cause mortality in patients with established coronary artery disease. International Journal of Cardiology, 117, 97-102.
6. Concato, J., Horwitz, R.I., Feinstein, A.R., Elmore, J.G., & Schiff, S.F. (1992). Problems of comorbidity in mortality after prostatectomy. JAMA: The Journal of the American Medical Association, 267, 1077-1082.
7. Dunlop, D.D., Song, J., Manheim, L.M., Daviglus, M.L., & Chang, R.W. (2007). Racial/ethnic differences in the development of disability among older adults. American Journal of Public Health, 97, 2209-2215.
8. Elixhauser, A., Steiner, C., Harris, D.R., & Coffey, R.M. (1998). Comorbidity measures for use with administrative data. Medical Care, 36, 8-27.
9. Feinglass, J., Lin, S., Thompson, J., Sudano, J., Dunlop, D., Song, J., et al. (2007). Baseline health, socioeconomic status, and 10-year mortality among older middle-aged Americans: Findings from the Health and Retirement Study, 1992 2002. Journal of Gerontology. Series B, Psychological Sciences and Social Sciences, 62, S209 - S217.
10. Ferrier, M.B., Spuesens, E.B., Le Cessie, S., & Baatenburg de Jong, R.J. (2005). Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Archives of Otolaryngology- Head and Neck Surgery, 131, 27-32.
11. Fisher, E.S., Whaley, F.S., Krushat, W.M., Malenka, D.J., Fleming, C., Baron, J.A., et al. (1992). The accuracy of Medicare's hospital claims data: Progress has been made, but problems remain. American Journal of Public Health, 82, 243-248.
12. Fouad, M.N., Mayo, C.P., Funkhouser, E.M., Irene Hall, H., Urban, D.A., & Kiefe, C.I. (2004). Comorbidity independently predicted death in older prostate cancer patients, more of whom died with than from their disease. Journal of Clinical Epidemiology, 57, 721-729.
13. Freeman, V.L., Durazo-Arvizu, R., Keys, L.C., Johnson, M.P., Schafernak, K., & Patel, V.K. (2004). Racial differences in survival among men with prostate cancer and comorbidity at time of diagnosis. American Journal of Public Health, 94, 803-808.
14. Godley, P.A., Schenck, A.P., Amamoo, M.A., Schoenbach, V.J., Peacock, S., Manning, M., et al. (2003). Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. Journal of the National Cancer Institute, 95, 1702-1710.
15. Gomez, S.L., O'Malley, C.D., Stroup, A., Shema, S.J., & Satariano, W.A. (2007). Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: Impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer, 7, 193.
16. Gross, C.P., Smith, B.D., Wolf, E., & Andersen, M. (2008). Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002 ? Cancer, 112, 900-908.
17. Hochberg, Y. (1988). A sharper Bonferroni procedure for multiple tests of significance. Biometrika, 75, 800-803.
18. Institute of Medicine of the National Academies. (2002). Unequal treatment: Confronting racial and ethnic disparities in health care. Retrieved March 13, 2009, from http://www.iom.edu/?id=16740
19. Johnson, N.E. (2000). The racial crossover in comorbidity, disability, and mortality. Demography, 37, 267-283.
20. Kelley-Moore, J.A., & Ferraro, K.F. (2004). The Black/White disability gap: Persistent inequality in later life ? Journal of Gerontology. Series B, Psychological Sciences and Social Sciences, 59, S34 - S43.
21. Kestenbaum, B. (1992). A description of the extreme aged population based on improved Medicare enrollment data. Demography, 29, 565-580.
22. Kung, H.-C., Hoyert, D.L., Xu, J., & Murphy, S.L. (2008, April 24). Table 3. Number of deaths and death rates by age, race, and sex: United States, 2005. National Vital Statistics Reports, 56 (10). Retrieved January 17, 2008, from http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56-10.pdf
23. Lesens, O., Methlin, C., Hansmann, Y., Remy, V., Martinot, M., Bergin, C., et al. (2003). Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: A prospective study using the Charlson weighted index of comorbidity. Infection Control and Hospital Epidemiology, 24, 890-896.
24. Librero, J., Peiro, S., & Ordinana, R. (1999). Chronic comorbidity and outcomes of hospital care: Length of stay, mortality, and readmission at 30 and 365 days. Journal of Clinical Epidemiology, 52, 171-179.
25. Manton, K.G., Poss, S.S., & Wing, S. (1979). The Black/White mortality crossover: Investigation from the perspective of the components of aging. Gerontologist, 19, 291-300.
26. Martins, M., & Blais, R. (2006). Evaluation of comorbidity indices for inpatient mortality prediction models. Journal of Clinical Epidemiology, 59, 665-669.
27. Massey, D., & Denton, N. (1988). The dimensions of residential segregation. Social Forces, 67, 281-315.
28. Mayberry, R.M., Coates, R.J., Hill, H.A., Click, L.A., Chen, V.W., Austin, D.F., et al. (1995). Determinants of Black/White differences in colon cancer survival. Journal of the National Cancer Institute, 87, 1686-1693.
29. McGee, D., Cooper, R., Liao, Y., & Durazo-Arvizu, R. (1996). Patterns of comorbidity and mortality risk in Blacks and Whites. Annals of Epidemiology, 6, 381-385.
30. Miles, T.P., & Bernard, M.A. (1992). Morbidity, disability, and health status of Black American elderly: A new look at the oldest-old. Journal of the American Geriatrics Society, 40, 1047-1054.
31. Monami, M., Lambertucci, L., Lamanna, C., Lotti, E., Marsili, A., Masotti, G., et al. (2007). Are comorbidity indices useful in predicting all-cause mortality in Type 2 diabetic patients? Comparison between Charlson index and disease count. Aging Clinical and Experimental Research, 19, 492-496.
32. The National Comprehensive Cancer Network (NCCN). (2004). NCCN Clinical Practice Guidelines in Oncology: Prostate cancer. Retrieved March 13, 2009, from http://www.nccn.org/professionals/physician-gls/PDF/prostate.pdf
33. Ouellette, J.R., Small, D.G., & Termuhlen, P.M. (2004). Evaluation of Charlson-age comorbidity index as predictor of morbidity and mortality in patients with colorectal carcinoma. Journal of Gastrointestinal Surgery, 8, 1061-1067.
34. Polednak, A.P., & Flannery, J.T. (1992). Black versus White racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer, 70, 2152-2158.
35. Sachdev, M., Sun, J.L., Tsiatis, A.A., Nelson, C.L., Mark, D.B., & Jollis, J.G. (2004). The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. Journal of the American College of Cardiology, 43, 576-582.
36. Schapira, M.M., McAuliffe, T.L., & Nattinger, A.B. (1995). Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Medical Care, 33, 1079-1088.
37. Sudano, J.J., & Baker, D.W. (2006). Explaining US racial/ethnic disparities in health declines and mortality in late middle age: The roles of socioeconomic status, health behaviors, and health insurance. Social Science & Medicine, 62, 909-922.
38. Sundararajan, V., Henderson, T., Perry, C., Muggivan, A., Quan, H., & Ghali, W.A. (2004). New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. Journal of Clinical Epidemiology, 57, 1288-1294.
39. Tammemagi, C.M., Nerenz, D., Neslund-Dudas, C., Feldkamp, C., & Nathanson, D. (2005). Comorbidity and survival disparities among Black and White patients with breast cancer. JAMA: The Journal of the American Medical Association, 294, 1765-1772.
40. Tammemagi, C.M., Neslund-Dudas, C., Simoff, M., & Kvale, P. (2004). In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. Journal of Clinical Epidemiology, 57, 597-609.
41. West, D.W., Satariano, W.A., Ragland, D.R., & Hiatt, R.A. (1996). Comorbidity and breast cancer survival: A comparison between Black and White women. Annals of Epidemiology, 6, 413-419.
42. Wilt, T.J., Macdonald, R., Rutks, I., Shamliyan, T.A., Taylor, B.C., & Kane, R.L. (2008). Systematic review: The comparative effectiveness and harms of treatments for clinically localized prostate cancer. Annals of Internal Medicine, 148, 435-448.
43. Yancik, R., Wesley, M.N., Ries, L.A., Havlik, R.J., Long, S., Edwards, B.K., et al. (1998). Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: A population-based study. Cancer, 82, 2123-2134.